These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 20507096

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Predicting the biodistribution of radiolabeled cMORF effector in MORF-pretargeted mice.
    Liu G, Dou S, He J, Liu X, Rusckowski M, Hnatowich DJ.
    Eur J Nucl Med Mol Imaging; 2007 Feb; 34(2):237-46. PubMed ID: 17021815
    [Abstract] [Full Text] [Related]

  • 3. An improved method for covalently conjugating morpholino oligomers to antitumor antibodies.
    He J, Liu G, Dou S, Gupta S, Rusckowski M, Hnatowich D.
    Bioconjug Chem; 2007 Feb; 18(3):983-8. PubMed ID: 17385902
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pretargeting in tumored mice with radiolabeled morpholino oligomer showing low kidney uptake.
    Liu G, He J, Dou S, Gupta S, Vanderheyden JL, Rusckowski M, Hnatowich DJ.
    Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):417-24. PubMed ID: 14691611
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Further investigations of morpholino pretargeting in mice--establishing quantitative relations in tumor.
    Liu G, He J, Dou S, Gupta S, Rusckowski M, Hnatowich DJ.
    Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1115-23. PubMed ID: 16133391
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tumor pretargeting in mice using (99m)Tc-labeled morpholino, a DNA analog.
    Liu G, Mang'era K, Liu N, Gupta S, Rusckowski M, Hnatowich DJ.
    J Nucl Med; 2002 Mar; 43(3):384-91. PubMed ID: 11884499
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Synthesis and in vitro characterization of a dendrimer-MORF conjugate for amplification pretargeting.
    Chen X, Dou S, Liu G, Liu X, Wang Y, Chen L, Rusckowski M, Hnatowich DJ.
    Bioconjug Chem; 2008 Aug; 19(8):1518-25. PubMed ID: 18646837
    [Abstract] [Full Text] [Related]

  • 14. A comparison of in vitro and in vivo stability in mice of two morpholino duplexes differing in chain length.
    He J, Liu G, Zhang S, Vanderheyden JL, Liu N, Liu C, Zhang Y, Gupta S, Rusckowski M, Hnatowich DJ.
    Bioconjug Chem; 2003 Aug; 14(5):1018-23. PubMed ID: 13129406
    [Abstract] [Full Text] [Related]

  • 15. A preclinical 188Re tumor therapeutic investigation using MORF/cMORF pretargeting and an antiTAG-72 antibody CC49.
    Liu G, Dou S, Baker S, Akalin A, Cheng D, Chen L, Rusckowski M, Hnatowich DJ.
    Cancer Biol Ther; 2010 Oct 15; 10(8):767-74. PubMed ID: 21099368
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Replacing 99mTc with 111In improves MORF/cMORF pretargeting by reducing intestinal accumulation.
    Liu G, Cheng D, Dou S, Chen X, Liang M, Pretorius PH, Rusckowski M, Hnatowich DJ.
    Mol Imaging Biol; 2009 Oct 15; 11(5):303-7. PubMed ID: 19326173
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.